GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Cyclically Adjusted PB Ratio

YIFAN PHARMACEUTICAL CO (SZSE:002019) Cyclically Adjusted PB Ratio : 2.46 (As of May. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Cyclically Adjusted PB Ratio?

As of today (2024-05-26), YIFAN PHARMACEUTICAL CO's current share price is ¥13.50. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥5.49. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio for today is 2.46.

The historical rank and industry rank for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:002019' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.88   Med: 6.31   Max: 15.38
Current: 2.46

During the past years, YIFAN PHARMACEUTICAL CO's highest Cyclically Adjusted PB Ratio was 15.38. The lowest was 1.88. And the median was 6.31.

SZSE:002019's Cyclically Adjusted PB Ratio is ranked worse than
59.54% of 692 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs SZSE:002019: 2.46

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's adjusted book value per share data for the three months ended in Mar. 2024 was ¥6.858. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥5.49 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


YIFAN PHARMACEUTICAL CO Cyclically Adjusted PB Ratio Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Cyclically Adjusted PB Ratio Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.49 5.51 4.35 2.59 2.78

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 2.91 2.64 2.78 2.02

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio falls into.



YIFAN PHARMACEUTICAL CO Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=13.50/5.49
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, YIFAN PHARMACEUTICAL CO's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.858/115.2271*115.2271
=6.858

Current CPI (Mar. 2024) = 115.2271.

YIFAN PHARMACEUTICAL CO Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.118 98.200 1.312
201409 2.197 98.900 2.560
201412 2.311 99.000 2.690
201503 2.388 99.900 2.754
201506 2.467 99.500 2.857
201509 2.536 100.500 2.908
201512 2.596 100.600 2.973
201603 2.721 102.200 3.068
201606 2.888 101.400 3.282
201609 3.045 102.400 3.426
201612 3.202 102.600 3.596
201703 3.385 103.200 3.779
201706 3.523 103.100 3.937
201709 5.005 104.100 5.540
201712 5.359 104.500 5.909
201803 5.631 105.300 6.162
201806 5.658 104.900 6.215
201809 5.464 106.600 5.906
201812 5.488 106.500 5.938
201903 5.607 107.700 5.999
201906 5.684 107.700 6.081
201909 5.917 109.800 6.209
201912 6.063 111.200 6.283
202003 6.354 112.300 6.520
202006 6.633 110.400 6.923
202009 6.792 111.700 7.006
202012 6.828 111.500 7.056
202103 6.981 112.662 7.140
202106 6.988 111.769 7.204
202109 7.010 112.215 7.198
202112 6.917 113.108 7.047
202203 7.013 114.335 7.068
202206 6.992 114.558 7.033
202209 7.162 115.339 7.155
202212 7.188 115.116 7.195
202303 7.226 115.116 7.233
202306 7.326 114.558 7.369
202309 7.329 115.339 7.322
202312 6.750 114.781 6.776
202403 6.858 115.227 6.858

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines